II. Indications

  1. Breast Cancer Screening in high risk women
    1. BRCA1 or BRCA2 genetic mutation
    2. First degree relative with BRCA1 or BRCA2
    3. Radiation exposure to chest under age 30 years
    4. Lifetime Breast Cancer risk estimated >20%
    5. Other Genetic Syndromes (and an affected 1d relative)
      1. Li-Fraumeni Syndrome
      2. Cowden syndrome
      3. Bannayan-Riley-Ruvalcaba Syndrome
    6. References
      1. Saslow (2007) CA Cancer J Clin 57: 75-89 [PubMed]
  2. Breast Cancer evaluation
    1. Define extent of Breast Cancer index lesion
    2. Identify concurrent cancer in contralateral Breast
    3. Assess response to Chemotherapy
    4. Define new Breast Cancers in those with implants
    5. Assess for suspected residual cancer post-surgery
    6. Inconclusive Mammogram, breast Ultrasound, CBE
    7. References
      1. Silverstein (2005) J Am Coll Surg 201:586-97 [PubMed]

III. Protocol: Breast Cancer Screening

  1. Annual Breast MRI starting at age 30 in high risk women
  2. Continue Mammograms and Clinical Breast Exams

IV. Efficacy: Breast Cancer Screening

V. Disadvantages: Breast Cancer Screening

  1. Too expensive for general population screening

Images: Related links to external sites (from Bing)

Related Studies (from Trip Database) Open in New Window

Ontology: Magnetic resonance imaging of breast (C0344104)

Concepts Diagnostic Procedure (T060)
SnomedCT 241615005
English MRI of breast (procedure), Magnetic resonance imaging of breast (procedure), breast MRI, Magnetic resonance imaging of breast, magnetic resonance imaging of breast (procedure), magnetic resonance imaging of breast, MRI breast, MRI of breast
Spanish RM de mama, resonancia magn├ętica de mama (procedimiento), resonancia magn├ętica de mama